Clinical Trial

Vagal Approaches on Long COVID-19

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to explore whether two general wellness products, alone or combined, can support individuals experiencing Long COVID symptoms. Both wellness products stimulate the vagus nerve - a nerve that helps regulate stress, relaxation, mood, breathing, heart rate, inflammation, and digestion. The investigators will use a Fitbit to track participants' health measurements including, but not limited to, activity, heart rate, and heart rate variability, and participants will be asked to complete surveys about their experience. This information will be collected into a repository where participants can share their experiences with Long COVID symptoms.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-22; most recent amendment 2026-01-05.
Status change: Not Yet Recruiting → Completed 2026-01-05
Trial Details
NCT Number NCT07190105
Lead Sponsor Leidos Life Sciences
Conditions Long COVID Symptoms
Enrollment 546 participants
Start Date 2025-10-27
Primary Completion 2025-12-11 (estimated)
Study Completion 2025-12-11 (estimated)
Updated on ClinicalTrials.gov 2026-01-07